DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $255,543 | +23.1% | 1,030 | +19.1% | 0.18% | +29.4% |
| Q2 2023 | $207,600 | -39.7% | 865 | -36.6% | 0.14% | -38.4% |
| Q1 2023 | $344,035 | -5.0% | 1,365 | 0.0% | 0.23% | -5.7% |
| Q4 2022 | $362,298 | +2.6% | 1,365 | 0.0% | 0.25% | +5.6% |
| Q3 2022 | $353,000 | -14.5% | 1,365 | -16.3% | 0.23% | -2.9% |
| Q2 2022 | $413,000 | -13.6% | 1,630 | 0.0% | 0.24% | -6.6% |
| Q1 2022 | $478,000 | +2.8% | 1,630 | +15.4% | 0.26% | -5.9% |
| Q4 2021 | $465,000 | +8.1% | 1,413 | 0.0% | 0.27% | +0.4% |
| Q3 2021 | $430,000 | +13.5% | 1,413 | 0.0% | 0.27% | +16.2% |
| Q2 2021 | $379,000 | +19.2% | 1,413 | 0.0% | 0.23% | +12.0% |
| Q1 2021 | $318,000 | +1.3% | 1,413 | 0.0% | 0.21% | -6.7% |
| Q4 2020 | $314,000 | +3.3% | 1,413 | 0.0% | 0.22% | -11.5% |
| Q3 2020 | $304,000 | +111.1% | 1,413 | +73.8% | 0.25% | +75.7% |
| Q2 2020 | $144,000 | -26.5% | 813 | -42.5% | 0.14% | -22.6% |
| Q1 2020 | $196,000 | -9.7% | 1,413 | 0.0% | 0.19% | +3.9% |
| Q4 2019 | $217,000 | -28.6% | 1,413 | -32.7% | 0.18% | -26.6% |
| Q3 2019 | $304,000 | +1.3% | 2,100 | 0.0% | 0.24% | +1.2% |
| Q2 2019 | $300,000 | +8.3% | 2,100 | 0.0% | 0.24% | +4.3% |
| Q1 2019 | $277,000 | +27.6% | 2,100 | 0.0% | 0.23% | +16.7% |
| Q4 2018 | $217,000 | -4.8% | 2,100 | 0.0% | 0.20% | +10.0% |
| Q3 2018 | $228,000 | +10.1% | 2,100 | 0.0% | 0.18% | -0.6% |
| Q2 2018 | $207,000 | +0.5% | 2,100 | 0.0% | 0.18% | +3.4% |
| Q1 2018 | $206,000 | +12.6% | 2,100 | +6.3% | 0.18% | +6.1% |
| Q4 2017 | $183,000 | +10.9% | 1,975 | +2.6% | 0.16% | +8.6% |
| Q3 2017 | $165,000 | +1.9% | 1,925 | 0.0% | 0.15% | +4.1% |
| Q2 2017 | $162,000 | +350.0% | 1,925 | +352.9% | 0.15% | +305.6% |
| Q1 2017 | $36,000 | -76.0% | 425 | -77.9% | 0.04% | -74.8% |
| Q4 2016 | $150,000 | – | 1,925 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |